- Home
- BWFG vs IVVD Comparison
BWFG vs IVVD Comparison
Compare BWFG & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWFG
- IVVD
- Stock Information
- Founded
- BWFG 2002
- IVVD 2020
- Country
- BWFG United States
- IVVD United States
- Employees
- BWFG N/A
- IVVD N/A
- Industry
- BWFG Major Banks
- IVVD Biotechnology: Pharmaceutical Preparations
- Sector
- BWFG Finance
- IVVD Health Care
- Exchange
- BWFG Nasdaq
- IVVD Nasdaq
- Market Cap
- BWFG 341.5M
- IVVD 377.4M
- IPO Year
- BWFG N/A
- IVVD 2021
- Fundamental
- Price
- BWFG $42.93
- IVVD $1.40
- Analyst Decision
- BWFG Buy
- IVVD Strong Buy
- Analyst Count
- BWFG 2
- IVVD 5
- Target Price
- BWFG $53.00
- IVVD $6.11
- AVG Volume (30 Days)
- BWFG 21.5K
- IVVD 5.9M
- Earning Date
- BWFG 10-23-2025
- IVVD 11-06-2025
- Dividend Yield
- BWFG 1.86%
- IVVD N/A
- EPS Growth
- BWFG 88.52
- IVVD N/A
- EPS
- BWFG 3.66
- IVVD N/A
- Revenue
- BWFG $94,282,000.00
- IVVD $46,210,000.00
- Revenue This Year
- BWFG $66.56
- IVVD $102.11
- Revenue Next Year
- BWFG $14.45
- IVVD $151.51
- P/E Ratio
- BWFG $11.75
- IVVD N/A
- Revenue Growth
- BWFG 30.93
- IVVD 1941.08
- 52 Week Low
- BWFG $26.39
- IVVD $0.35
- 52 Week High
- BWFG $48.03
- IVVD $2.74
- Technical
- Relative Strength Index (RSI)
- BWFG 47.94
- IVVD 40.75
- Support Level
- BWFG $42.50
- IVVD $1.74
- Resistance Level
- BWFG $43.74
- IVVD $2.00
- Average True Range (ATR)
- BWFG 1.33
- IVVD 0.25
- MACD
- BWFG -0.02
- IVVD -0.08
- Stochastic Oscillator
- BWFG 32.89
- IVVD 1.55
About BWFG Bankwell Financial Group Inc.
Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.
About IVVD Invivyd Inc.
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.